{"retracted":false,"update":{"timestamp":1467331200000,"doi":"10.1136/annrheumdis-2013-204016corr1","type":"correction"},"doi":"10.1136/annrheumdis-2013-204016","journal":"Annals of the Rheumatic Diseases","publisher":"BMJ","title":"Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study: Table 3"}
